Designed & Developed by M/s Akiko Sherman Infotech, Hosted by NIC/NICSI Content Provided by Pharmacopoeia Commission for Indian Medicine & Homoeopathy
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) was initially established as Pharmacopoeia Commission for Indian Medicine (PCIM) in the year 2010 and later in pursuance to the decision of Central Government (dated 20th March 2014), Homoeopathy was incorporated and the Commission was renamed as Pharmacopoeia Commission for Indian Medicine & Homoeopathy. It was constituted with a primary mandate of publishing Pharmacopoeias and Formularies for drugs/formulations used in Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) systems of Medicine. The Commission serves as an umbrella organization for Ayurvedic, Siddha, Unani and Homoeopathy Pharmacopoeia Committees. Pharmacopoeial Laboratory for Indian Medicine (PLIM) and Homoeopathic Pharmacopoeia Laboratory (HPL) are its supporting structures.
Commission is working in the view of excellence for the development of regulatory standards of Ayurveda, Siddha, Unani & Homoeopathy (ASU&H) drugs. It is committed to promote and preserve the well-being of humans and animals in India, by bringing out official standards for quality of drugs included in Ayurveda, Siddha, Unani & Homoeopathy systems of Medicine used by AYUSH professionals and consumers.
Commission is working in association with international organizations such as United State Pharmacopoeia (USP) Convention, World Health Organization (WHO) and other country regulators to bring-up the ASU&H pharmacopoeias at par with international standards. Commission is under process of developing Botanical Reference Standards (BRS) authentic reference raw materials used in the ASU&H medicine. The Phytochemical Reference Standard (PRS) is maintained by Commission to support the ASU&H manufactures for the Quality Control of ASU&H Medicines. Commission is committed to carry out drug research on ASU products and other related scientific information and publishes regularly to strengthen the ASU&H medicines.
Commission regularly conduct national/international conferences/seminars/symposia/workshops and meetings in selected areas time to time, to provide updated regular training to the regulatory authorities and stake holders.
Dr. D.C. Katoch
Director (Additional Charge)